Rhumbline Advisers Sanara Med Tech Inc. Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Sanara Med Tech Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 3,345 shares of SMTI stock, worth $100,851. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,345
Previous 3,302
1.3%
Holding current value
$100,851
Previous $122,000
22.95%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SMTI
# of Institutions
39Shares Held
739KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY197KShares$5.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA146KShares$4.39 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA84.5KShares$2.55 Million0.0% of portfolio
-
Janney Montgomery Scott LLC56.2KShares$1.69 Million0.0% of portfolio
-
State Street Corp Boston, MA53.8KShares$1.62 Million0.0% of portfolio
About Sanara MedTech Inc.
- Ticker SMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 8,303,730
- Market Cap $250M
- Description
- Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and...